Page 16 - Accelerate Diagnostics News Today

Antimicrobial Susceptibility Testing Market worth $4.2 billion by 2025 – Size, Industry Trends, Key Players and Forecast

.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... TUCSON, Ariz. — Accelerate Diagnostics Inc. (AXDX) on Thursday reported a loss of $24.2 million in its first quarter. The Tucson, Arizona-based company said it had a loss of 41 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Za...

Accelerate Diagnostics Reports First Quarter 2021 Financial Results News provided by Share this article Share this article TUCSON, Ariz., May 6, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2021. "First quarter financial results were consistent with our expectations," commented Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, Inc.  "We also progressed key commercial and...

Press release content from Business Wire. The AP news staff was not involved in its creation. Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors May 5, 2021 GMT SARASOTA, Fla.--(BUSINESS WIRE)--May 5, 2021-- Lumos Diagnostics announced today the expansion of its board with the appointment of three new independent directors to support the continued growth of the company’s rapid point-of-care diagnostic products and services business. Bronwyn Le Grice, Lawrence Mehren an...

Accelerate Diagnostics to Host Call to Review First Quarter 2021 Results News provided by Share this article Share this article TUCSON, Ariz., May 5, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that management will host a conference call on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time to review 2021 first quarter financial results. To listen by phone, dial +1.877.883.0383 and enter Elite Entry Number: 4747452. International participants may dial +1.412....

Share this article Share this article TUCSON, Ariz., April 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the companys supply chain, serving as a final-stage manufacturing and sterilization center.   The new 120,000 square-foot facility will be built on approximately 32 acres at the northeast corner ...

Share this article Share this article TUCSON, Ariz., Feb. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and full year ended December 31, 2020. "We were pleased with the improvement in our go-live execution over the course of 2020, which drove a material increase in our live instruments in the fourth quarter and led to a 63% increase in our revenue-generating installed base during the year," commented Jack Phillips...

19 The Antimicrobial Susceptibility Testing Market research study considers the present scenario of the market and With major regions, from angles of manufacturers, product types and end industries. It covers a detailed overview of several market growth industry analysis, restraints, and trends. The report covers both the demand and supply aspects of the market. This research report on the Antimicrobial Susceptibility Testing market covers sizing and forecast, market share, industry trends, g...

Share it When Accelerate Diagnostics last week filed a $150 million shelf registration with the Securities and Exchange Commission (SEC) to signal a possible future share offering, it was one of almost 60 companies to do so in just the first month of the year — the highest in a decade.  Should companies continue to make filings at the same rate as in January, this year could turn out to be record-setting for the tactic. The strategy gives companies the flexibility to raise capital quickly t...

Share this article Share this article TUCSON, Ariz., Feb. 1, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time. A live audiocast of the session will be accessible through the companys investor relations website at  ir.axdx.com. A replay of the audiocast will be available for at least 3...